Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy, New England Journal of Medicine, vol.345, issue.12, pp.861-870, 2001. ,
DOI : 10.1056/NEJMoa011161
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials, European Heart Journal, vol.32, issue.12, pp.1493-1502, 2011. ,
DOI : 10.1093/eurheartj/ehr017
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes, New England Journal of Medicine, vol.345, issue.12, pp.870-878, 2001. ,
DOI : 10.1056/NEJMoa011489
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function, Clinical Journal of the American Society of Nephrology, vol.11, issue.1, pp.90-100, 2016. ,
DOI : 10.2215/CJN.01730215
URL : http://cjasn.asnjournals.org/content/11/1/90.full.pdf
Managing Hyperkalemia Caused by Inhibitors of the Renin???Angiotensin???Aldosterone System, New England Journal of Medicine, vol.351, issue.6, pp.585-92, 2004. ,
DOI : 10.1056/NEJMra035279
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: Lessons from randomized controlled trials and registries, International Journal of Cardiology, vol.177, issue.3, pp.731-734, 2014. ,
DOI : 10.1016/j.ijcard.2014.11.004
Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future, Pharmacological Research, vol.113, pp.585-91, 2016. ,
DOI : 10.1016/j.phrs.2016.09.039
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval, International Journal of Cardiology, vol.216, pp.46-51, 2016. ,
DOI : 10.1016/j.ijcard.2016.04.127
Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease, The American Journal of Cardiology, vol.109, issue.10, pp.1510-1513, 2012. ,
DOI : 10.1016/j.amjcard.2012.01.367
Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy: Results From the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), Circulation: Heart Failure, vol.7, issue.1, pp.51-59, 2014. ,
DOI : 10.1161/CIRCHEARTFAILURE.113.000792
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial, Diabetologia, vol.16, issue.Suppl 1, pp.44-50, 2011. ,
DOI : 10.1007/s00125-010-1922-6
Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease: Findings From Propensity-Matched Studies, Circulation: Heart Failure, vol.3, issue.2, pp.253-60, 2010. ,
DOI : 10.1161/CIRCHEARTFAILURE.109.899526
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909749
Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure, Journal of the American College of Cardiology, vol.60, issue.20, pp.2082-2091, 2012. ,
DOI : 10.1016/j.jacc.2012.07.048
Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study, Clinical Journal of the American Society of Nephrology, vol.5, issue.5, pp.762-771, 2010. ,
DOI : 10.2215/CJN.05850809
Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race, Nephron Clinical Practice, vol.120, issue.1, pp.8-16, 2012. ,
DOI : 10.1159/000329511
Hypokalemia, Its Contributing Factors and Renal Outcomes in Patients with Chronic Kidney Disease, PLoS ONE, vol.19, issue.7, p.67140, 2013. ,
DOI : 10.1371/journal.pone.0067140.s004
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease, American Journal of Nephrology, vol.41, issue.6, pp.456-63, 2015. ,
DOI : 10.1159/000437151
Methodology for potassium analysis. Potassium, its biologic significance, p.9, 1983. ,
A Comparison of Serum versus Heparinized Plasma for Routine Chemistry Tests, American Journal of Clinical Pathology, vol.61, issue.1, pp.108-121, 1974. ,
DOI : 10.1093/ajcp/61.1.108
Timing of Onset of CKD-Related Metabolic Complications, Journal of the American Society of Nephrology, vol.20, issue.1, pp.164-71, 2009. ,
DOI : 10.1681/ASN.2008020159
URL : https://hal.archives-ouvertes.fr/inserm-00555033
When do we need competing risks methods for survival analysis in nephrology?, Nephrology Dialysis Transplantation, vol.28, issue.11, pp.2670-2677, 2013. ,
DOI : 10.1093/ndt/gft355
URL : https://academic.oup.com/ndt/article-pdf/28/11/2670/6905007/gft355.pdf
Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int, issue.3, pp.1-150, 2012. ,
Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data, European Heart Journal, vol.38, issue.2, pp.104-116, 2017. ,
DOI : 10.1093/eurheartj/ehw129
Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia, Pharmacological Research, vol.118, pp.2-4, 2017. ,
DOI : 10.1016/j.phrs.2016.07.032
New Potassium Binders for the Treatment of Hyperkalemia, Hypertension, vol.66, issue.4, pp.731-739, 2015. ,
DOI : 10.1161/HYPERTENSIONAHA.115.04889
The association between serum potassium and mortality in patients with hypertension, Eur Heart J, vol.38, issue.2, pp.113-118, 2017. ,
Laboratory Evaluation of Potassium and Creatinine Among Ambulatory Patients Prescribed Spironolactone: Are We Monitoring for Hyperkalemia?, Annals of Pharmacotherapy, vol.16, issue.2, pp.193-200, 2007. ,
DOI : 10.1002/pds.1217
Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure, JAMA, vol.314, issue.18, pp.1973-1978, 2015. ,
DOI : 10.1001/jama.2015.11904